Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Cosmos Health signs distribution agreement with IMC, owner of Qatar's largest pharmacy chain. Secures purchase order of 31,000 Sky Premium Life units.
-
Cosmos Health advances its wholly owned CCX0722 hydrogel weight management patent application across the U.S., Europe, Australia, and Canada.
-
Cosmos Health's C-Sept PRO gains strong traction across leading Greek hospital groups, with annualized sales poised to exceed $1.3 million.
-
CHICAGO, June 23, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it...
-
Cumulative orderbook of over 25 million units secured through wholly owned subsidiary Cana Laboratories across multiple EU and international partners.Multi-year agreements extending up to 10 years...
-
CHICAGO, June 18, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that its...
-
Cosmos Health enters the global skincare market. Sales already underway in the United States.
-
Cosmos Health signs 1.72 million-unit contract manufacturing agreement With Pharmex S.A. across three dermatological products.
-
Cosmos Health provides update on United States portfolio.
-
Cosmos Health Receives New Contract Manufacturing Orders Totaling 253,657 Units Across a Range of Medicines